Found: 53
Select item for more details and to access through your institution.
CD99 Expression and Prognostic Impact in Glioblastoma: A Single-Center Cohort Study.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 7, p. 597, doi. 10.3390/cells13070597
- By:
- Publication type:
- Article
Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinoma in situ.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01486
- By:
- Publication type:
- Article
Indigenous Hepatitis E Virus Genotype 1 Infection, Uruguay.
- Published in:
- 2014
- By:
- Publication type:
- Letter
Are There Differences in Androgen Receptor Expression in Invasive Breast Cancer in African (Tanzanian) Population in Comparison With the Caucasian (Italian) Population?
- Published in:
- Frontiers in Endocrinology, 2018, p. 1, doi. 10.3389/fendo.2018.00137
- By:
- Publication type:
- Article
Androgen and oestrogen receptors as potential prognostic markers for patients with ductal carcinoma in situ treated with surgery and radiotherapy.
- Published in:
- International Journal of Experimental Pathology, 2017, v. 98, n. 5, p. 289, doi. 10.1111/iep.12253
- By:
- Publication type:
- Article
Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy?
- Published in:
- 2018
- By:
- Publication type:
- journal article
The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 187, n. 1, p. 155, doi. 10.1007/s10549-021-06109-7
- By:
- Publication type:
- Article
Insulin-like growth factor-1 receptor (IGF-1R) expression on circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 1, p. 61, doi. 10.1007/s10549-020-05596-4
- By:
- Publication type:
- Article
Precision medicine: PI3K targeting in advanced breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Is Ki67 still a powerful ally in predicting the clinical benefit of anthracyclines for the adjuvant treatment of early breast cancer?
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 168, n. 3, p. 767, doi. 10.1007/s10549-017-4630-9
- By:
- Publication type:
- Article
Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 159, n. 1, p. 79, doi. 10.1007/s10549-016-3923-8
- By:
- Publication type:
- Article
Efficacy of endocrine therapy in relation to progesterone receptor and Ki67 expression in advanced breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 152, n. 1, p. 57, doi. 10.1007/s10549-015-3423-2
- By:
- Publication type:
- Article
Benefit from anthracyclines in relation to biological profiles in early breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 144, n. 2, p. 307, doi. 10.1007/s10549-013-2819-0
- By:
- Publication type:
- Article
Erratum to: Benefit from anthracyclines in relation to biological profiles in early breast cancer.
- Published in:
- 2014
- By:
- Publication type:
- Erratum
Safety, Tolerability and Biological Effects of Long-Term Metronomic Administration of Non-Cytotoxic Anti-Angiogenic Agents.
- Published in:
- Oncology, 2010, v. 77, n. 6, p. 358, doi. 10.1159/000275830
- By:
- Publication type:
- Article
Clinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence.
- Published in:
- Cancer Management & Research, 2018, v. 10, p. 3083, doi. 10.2147/CMAR.S137772
- By:
- Publication type:
- Article
Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results.
- Published in:
- 2001
- By:
- Publication type:
- journal article
CDK4/6-Inhibitors Versus Chemotherapy in Advanced HR+/HER2-Negative Breast Cancer: Results and Correlative Biomarker Analyses of the KENDO Randomized Phase II Trial.
- Published in:
- Oncologist, 2024, v. 29, n. 5, p. e622, doi. 10.1093/oncolo/oyad337
- By:
- Publication type:
- Article
Phase II Study of Dehydroepiandrosterone in Androgen Receptor‐Positive Metastatic Breast Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 743, doi. 10.1634/theoncologist.2018-0243
- By:
- Publication type:
- Article
A Phase II Study of a Dose-Density Regimen With Fluorouracil, Epirubicin, and Cyclophosphamide on Days 1 and 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer.
- Published in:
- Oncologist, 2015, v. 20, n. 3, p. 239, doi. 10.1634/theoncologist.2014-0326
- By:
- Publication type:
- Article
Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience.
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 8, p. 573, doi. 10.3390/diagnostics10080573
- By:
- Publication type:
- Article
Immunotherapy: The end of the "dark age" for metastatic triple‐negative breast cancer?
- Published in:
- Breast Journal, 2020, v. 26, n. 4, p. 739, doi. 10.1111/tbj.13662
- By:
- Publication type:
- Article
Postoperative Hyperprolactinemia Could Predict Longer Disease-Free and Overall Survival in Node-Negative Breast Cancer Patients.
- Published in:
- Oncology, 2002, v. 63, n. 4, p. 370, doi. 10.1159/000066228
- By:
- Publication type:
- Article
Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920985632
- By:
- Publication type:
- Article
Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920985632
- By:
- Publication type:
- Article
The impact of progesterone receptor expression on prognosis of patients with rapidly proliferating, hormone receptor-positive early breast cancer: a post hoc analysis of the IBIS 3 trial.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835919888999
- By:
- Publication type:
- Article
Progress with palbociclib in breast cancer: latest evidence and clinical considerations.
- Published in:
- Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 2, p. 83, doi. 10.1177/1758834016677961
- By:
- Publication type:
- Article
Serum EGFR and Serum HER-2/neu Are Useful Predictive and Prognostic Markers in Metastatic Breast Cancer Patients Treated With Metronomic Chemotherapy.
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 3, p. 509, doi. 10.1002/cncr.22825
- By:
- Publication type:
- Article
Role of androgen and estrogen receptors as prognostic and potential predictive markers of ductal carcinoma in situ of the breast.
- Published in:
- International Journal of Biological Markers, 2015, v. 30, n. 4, p. e425, doi. 10.5301/jbm.5000163
- By:
- Publication type:
- Article
Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer?
- Published in:
- Journal of Oncology, 2019, p. 1, doi. 10.1155/2019/1393505
- By:
- Publication type:
- Article
Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer.
- Published in:
- BMC Cancer, 2006, v. 6, p. 225, doi. 10.1186/1471-2407-6-225
- By:
- Publication type:
- Article
Transport of tools to food sites in tufted capuchin monkeys (Cebus apella).
- Published in:
- Animal Cognition, 2004, v. 7, n. 3, p. 193, doi. 10.1007/s10071-004-0213-3
- By:
- Publication type:
- Article
Tufted capuchins (Cebus apella) attribute value to foods and tools during voluntary exchanges with humans.
- Published in:
- Animal Cognition, 2004, v. 7, n. 1, p. 19, doi. 10.1007/s10071-003-0181-z
- By:
- Publication type:
- Article
A Pictorial Essay Describing the CT Imaging Features of COVID-19 Cases throughout the Pandemic with a Special Focus on Lung Manifestations and Extrapulmonary Vascular Abdominal Complications.
- Published in:
- Biomedicines, 2023, v. 11, n. 8, p. 2113, doi. 10.3390/biomedicines11082113
- By:
- Publication type:
- Article
Analysis of PD-L1 and CD3 Expression in Glioblastoma Patients and Correlation with Outcome: A Single Center Report.
- Published in:
- Biomedicines, 2023, v. 11, n. 2, p. 311, doi. 10.3390/biomedicines11020311
- By:
- Publication type:
- Article
Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1151194
- By:
- Publication type:
- Article
Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-11721-9
- By:
- Publication type:
- Article
The Predictive and Prognostic Role of RAS–RAF–MEK–ERK Pathway Alterations in Breast Cancer: Revision of the Literature and Comparison with the Analysis of Cancer Genomic Datasets.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5306, doi. 10.3390/cancers14215306
- By:
- Publication type:
- Article
Dissecting Molecular Heterogeneity of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients through Copy Number Aberration (CNA) and Single Nucleotide Variant (SNV) Single Cell Analysis.
- Published in:
- Cancers, 2022, v. 14, n. 16, p. 3925, doi. 10.3390/cancers14163925
- By:
- Publication type:
- Article
Can Systems Biology Advance Clinical Precision Oncology?
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6312, doi. 10.3390/cancers13246312
- By:
- Publication type:
- Article
Single-Cell NGS-Based Analysis of Copy Number Alterations Reveals New Insights in Circulating Tumor Cells Persistence in Early-Stage Breast Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2490, doi. 10.3390/cancers12092490
- By:
- Publication type:
- Article
Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1-3 node-positive rapidly proliferating breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 125, n. 3, p. 775, doi. 10.1007/s10549-010-1257-5
- By:
- Publication type:
- Article
Perception that Oral Anticancer Treatments are Less Efficacious: Development of a Questionnaire to Assess the Possible Prejudices of Patients with Cancer.
- Published in:
- Breast Cancer Research & Treatment, 2005, v. 92, n. 3, p. 265, doi. 10.1007/s10549-005-3376-y
- By:
- Publication type:
- Article
Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A phase IB dose-finding trial of liposomal doxorubicin in combination with capecitabine in patients with pretreated metastatic breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 5, p. 871, doi. 10.1007/s00280-009-1092-8
- By:
- Publication type:
- Article
Simplified FOLFIRI in pre-treated patients with metastatic gastric cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 301, doi. 10.1007/s00280-008-0871-y
- By:
- Publication type:
- Article
Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 4, p. 667, doi. 10.1007/s00280-007-0652-z
- By:
- Publication type:
- Article
Pathologic complete remission rate after cisplatin-based primary chemotherapy in breast cancer: correlation with p63 expression.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 6, p. 965, doi. 10.1007/s00280-007-0551-3
- By:
- Publication type:
- Article
Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumab.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-07143-1
- By:
- Publication type:
- Article
Cisplatin in advanced salivary gland carcinoma. A phase II study of 25 patients.
- Published in:
- 1991
- By:
- Publication type:
- journal article